振东制药：拟为全资子公司提供不超过1亿元担保

Core Points - Zhendong Pharmaceutical announced that it will provide guarantees for its wholly-owned subsidiaries to secure a credit limit of up to RMB 100 million from financial institutions [1] - The company plans to provide a guarantee of up to RMB 50 million for Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. and up to RMB 50 million for Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd. [1] - After this guarantee, the total guarantee amount provided by the company to its subsidiaries will be RMB 150 million, which accounts for 4.09% of the company's latest audited net assets [1] Financial Performance - For the first half of 2025, Zhendong Pharmaceutical's revenue composition was as follows: 110.27% from pharmaceutical production and sales, 31.67% from medicinal herb planting, and 3.38% from technical services, with inter-segment eliminations accounting for -45.32% [1] - The company's market capitalization is currently RMB 6.8 billion [2]